Properties
Description
GalNAc-L96, a triantennary GalNAc ligand that efficiently binds to ASGPR, enables the synthesis of GalNAc-siRNA for enhanced hepatocyte targeting. T1 acts as a key intermediate in the synthesis of GalNAc-L96, aiding in the creation of precision therapeutic agents.
Molecular Formula
C8H18N2O2
Purity
≥98%, determined by HPLC.
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Conforms to structure, determined by 1H NMR.
